Genmab — November 2017
-
Og det er endda uden solide såvidt jeg kan se?
-
E L: We have seen several articles on the synergi between particularly pomalidomide and dara. This one is from august. https://www.researchgate.net/publication/319294230_Therapeutic_monoclonal_antibodies_in_combination_with_pomalidomide_can_overcome_refractoriness_to_both_agents_in_multiple_myeloma_A_case-based_approach
-
fra castor/pollux meddelelsen: Janssen har sammen med denne sBLA-ansøgning anmodet om Priority Review-status. FDA vil oplyse Janssen, hvorvidt der tildeles Priority Review-status inden for 60 dage, efter at de begynder deres behandling af ansøgningen, som starter i dag. Hvis FDA tildeler Priority Review-status, bør behandlingen af registreringsansøgningen kunne afsluttes inden for 6 måneder fra dags dato.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind